VYNE Therapeutics Inc. Common Stock (NASDAQ: VYNE) last traded at $28.56. The quote above updates while this page is open; the figures below are drawn from VYNE Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
VYNE Therapeutics Inc. Common Stock trades on NASDAQ under the ticker VYNE. Its market capitalisation is $76.25 million.
Valuation measures for VYNE Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $76.25M |
|---|---|
| Enterprise value | $54.86M |
| Price / sales | 133.77 |
| Price / book | 3.46 |
Trailing-twelve-month figures tagged in VYNE Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $570.0K |
|---|---|
| Net income (TTM) | -$26.48M |
| Operating margin | -5219.12% |
| Return on equity | -120.04% |
| Cash | $22.93M |
Range and volume for VYNE over the past 52 weeks.
| 52-week high | $46.95 |
|---|---|
| 52-week low | $14.03 |
| Volume | 93.3K |
| Average volume | 93.3K |
| Previous close | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.